DuPont De Nemours (DD) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
10 Feb, 2026Executive summary
Fourth quarter and full-year 2025 results exceeded guidance, with strong operational discipline and productivity driving earnings and margin improvement.
Full-year 2025 net sales rose 2% to $6.8 billion, with organic sales up 2%; adjusted EPS increased 16% year-over-year to $1.68.
Major portfolio transformation included the separation of Qnity Electronics and the divestiture of the Aramids business, both reflected as discontinued operations.
$500 million accelerated share repurchase executed in Q4 2025, with a $2 billion authorization announced and $1.5 billion remaining.
Strategic priorities for 2026 focus on above-market organic growth, business system enhancement, balanced capital allocation, and consistent financial delivery.
Financial highlights
Q4 2025 net sales were $1.7 billion, flat year-over-year; organic sales declined 1% but would have grown 1% adjusting for order timing.
Q4 2025 operating EBITDA was $409 million (margin 24.2%), up 4% year-over-year; full year operating EBITDA was $1.63 billion (margin 23.8%), up 6%.
Q4 2025 adjusted EPS was $0.46, up 18% year-over-year; full year adjusted EPS was $1.68, up 16%.
Transaction-adjusted free cash flow for FY25 was $689 million (98% conversion); Q4 2025 was $228 million (118% conversion).
Full year 2025 capital expenditures were $333 million.
Outlook and guidance
2026 guidance: net sales $7.08–$7.14 billion, organic sales growth of ~3%, operating margin expansion of 60–80 basis points, adjusted EPS of $2.25–$2.30.
Q1 2026 guidance: net sales ~$1.67 billion, operating EBITDA ~$395 million, adjusted EPS ~$0.48.
Medium-term (2025–2028): 3–4% CAGR organic net sales, 150–200bps EBITDA margin improvement, 8–10% adjusted EPS CAGR, >90% free cash flow conversion.
Healthcare and Water expected to grow mid-single digits; Diversified Industrials to grow low single digits.
Market stabilization expected in construction; automotive demand flat overall but EV builds to outpace.
Latest events from DuPont De Nemours
- Proxy covers director elections, executive pay, auditor ratification, and a reverse stock split.DD
Proxy filing23 Mar 2026 - Strong growth and margin gains offset by a $768M goodwill impairment charge.DD
Q1 20253 Feb 2026 - Adjusted EPS up 14% and full-year guidance raised amid electronics-driven growth.DD
Q2 20242 Feb 2026 - Q3 net sales up 4%, EBITDA up 11%, and full-year guidance raised as business separations progress.DD
Q3 202416 Jan 2026 - Strong 2024 results, margin gains, and Electronics separation set up continued 2025 growth.DD
Q4 20248 Jan 2026 - Proxy details director elections, CEO transition, and strong 2024 results with ESG focus.DD
Proxy Filing1 Dec 2025 - Annual meeting to vote on directors, executive pay, and auditor ratification, all board-backed.DD
Proxy Filing1 Dec 2025 - All proposals passed as strong results and strategic transformation plans were highlighted.DD
AGM 202524 Nov 2025 - Q2 2025 saw 3% sales growth, margin expansion, and raised guidance amid robust end-markets.DD
Q2 202523 Nov 2025